Francis L. Delmonico | Academic Influence

Francis L. Delmonico's AcademicInfluence.com Rankings

Francis L. Delmonico

Philosophy

#4721

World Rank

#7341

Historical Rank

#1328

USA Rank

Logic

#4506

World Rank

#5815

Historical Rank

#798

USA Rank

philosophy Degrees

Download Badge

Philosophy

Francis L. Delmonico's Degrees

Doctorate Medicine Harvard University

Why Is Francis L. Delmonico Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Francis L. Delmonico, MD, FACS is a surgeon, clinical professor and health expert in the field of transplantation. He serves on numerous committees and is affiliated with various leading organizations and institutions. He is the chief medical officer of the New England Organ Bank and Professor of Surgery, Part-Time at Harvard Medical School in Boston, Massachusetts, where he is emeritus director of renal transplantation. He served as president of The Transplantation Society from 2012 to 2014, an international non-profit organization based in Montreal, Canada that works with international transplantation physicians and researchers. He also served as the president of the United Network of Organ Sharing in 2005, which overseas the practice of organ donation and transplantation in the United States. He was appointed and still serves as an advisor to the World Health Organization in matters of organ donation and transplantation. He was appointed by Pope Francis to the Pontifical Academy of Science in 2016. In 2020, he became the recipient of the Medawar Prize of The Transplantation Society.

(See a Problem?)

Francis L. Delmonico's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Consensus statement on the live organ donor. (2000) (540)
A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines (2005) (519)
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. (2002) (500)
Report of a National Conference on Donation after Cardiac Death (2006) (489)
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. (1981) (485)
National Conference to Assess Antibody‐Mediated Rejection in Solid Organ Transplantation (2004) (470)
Transmission of lymphocytic choriomeningitis virus by organ transplantation. (2006) (446)
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. (2008) (442)
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors1 (2002) (437)
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. (1999) (411)
Organ donation and utilization in the United States, 2004 (2005) (384)
In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. (1990) (375)
ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1 (2001) (366)
Expanded criteria donors for kidney transplantation (2003) (356)
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. (1981) (347)
Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaver Donor (2002) (340)
Living-donor kidney transplantation: a review of the current practices for the live donor. (2005) (337)
Morbidity and Mortality After Living Kidney Donation, 1999–2001: Survey of United States Transplant Centers (2003) (330)
A Report of the Vancouver Forum on the Care of the Live Organ Donor: Lung, Liver, Pancreas, and Intestine Data and Medical Guidelines (2006) (314)
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. (1993) (294)
Aggressive pharmacologic donor management results in more transplanted organs1 (2003) (278)
Induction Of Kidney Allograft Tolerance After Transient Lymphohematopoietic Chimerism In Patients With Multiple Myeloma And End-Stage Renal Disease1 (2002) (274)
Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses (2006) (265)
Increasing the Opportunity of Live Kidney Donation by Matching for Two- and Three-Way Exchanges (2006) (254)
Organ trafficking and transplant tourism: a commentary on the global realities. (2008) (240)
Determinants of Discard of Expanded Criteria Donor Kidneys: Impact of Biopsy and Machine Perfusion (2008) (229)
SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2 (1992) (225)
Hormonal resuscitation yields more transplanted hearts, with improved early function1 (2003) (218)
Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. (1998) (204)
Donation After Cardiac Death as a Strategy to Increase Deceased Donor Liver Availability (2006) (193)
Increased Transplanted Organs from the Use of a Standardized Donor Management Protocol (2002) (184)
Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. (2002) (181)
Outcome of Kidney Transplantation Using Expanded Criteria Donors and Donation After Cardiac Death Kidneys: Realities and Costs (2007) (179)
A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1 (2003) (176)
Guidelines for the Psychosocial Evaluation of Living Unrelated Kidney Donors in the United States (2007) (174)
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. (1983) (173)
Organ trafficking and transplant tourism and commercialism : the declaration of Istanbul (2008) (170)
Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. (1999) (167)
Outcome of transplantation of organs procured from bacteremic donors. (1999) (167)
Utilizing List Exchange and Nondirected Donation through ‘Chain’ Paired Kidney Donations (2006) (166)
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era (2004) (164)
Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report (2010) (162)
Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. (2001) (161)
International practices of organ donation. (2012) (159)
The Report of a National Conference on the Wait List for Kidney Transplantation (2003) (156)
The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation (2011) (153)
FIRST REPORT OF THE UNITED NETWORK FOR ORGAN SHARING TRANSPLANT TUMOR REGISTRY: DONORS WITH A HISTORY OF CANCER1 (2000) (149)
Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With End-Stage Renal Disease (2011) (145)
Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. (1983) (141)
A call for government accountability to achieve national self-sufficiency in organ donation and transplantation (2011) (135)
Ethical incentives--not payment--for organ donation. (2002) (135)
The nondirected live-kidney donor: ethical considerations and practice guidelines: A National Conference Report1 (2002) (134)
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. (1996) (133)
The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. (2006) (132)
Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. (1995) (132)
Acute Humoral Rejection in Hepatitis C‐Infected Renal Transplant Recipients Receiving Antiviral Therapy (2003) (127)
Liver transplantation for primary hepatic cancer. (1992) (126)
Transplant tumor registry: donors with central nervous system tumors1. (2002) (117)
Diagnosis and Management of Tuberculosis in Transplant Donors: A Donor‐Derived Infections Consensus Conference Report † (2012) (115)
A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient (2007) (114)
LONG‐TERM METABOLIC AND QUALITY OF LIFE RESULTS WITH PANCREATIC/RENAL TRANSPLANTATION IN INSULIN‐DEPENDENT DIABETES MELLITUS (1991) (109)
Exchanging kidneys--advances in living-donor transplantation. (2004) (109)
EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTION (1984) (107)
Organ donation and utilization in the USA (2004) (104)
Living Kidney Donor Follow‐Up: State‐of‐the‐Art and Future Directions, Conference Summary and Recommendations (2011) (100)
Prevalence and significance of anti‐HLA and donor‐specific antibodies long‐term after renal transplantation (2005) (98)
Commentary: the WHO resolution on human organ and tissue transplantation. (2005) (96)
Lymphoproliferative disorders and hematologic malignancies following organ transplantation. (1989) (94)
Organ donor screening for infectious diseases: review of practice and implications for transplantation. (1998) (94)
Financial incentives for cadaver organ donation: an ethical reappraisal1 (2002) (92)
Approach to the Management of Allograft Recipients Following the Detection of Hepatitis B Virus in the Prospective Organ Donor (2001) (92)
De novo collapsing glomerulopathy in renal allografts. (1998) (92)
Impact of the Expanded Criteria Donor Allocation System on the Use of Expanded Criteria Donor Kidneys (2005) (89)
Organ Trafficking and Transplant Tourism: The Role of Global Professional Ethical Standards—The 2008 Declaration of Istanbul (2013) (88)
The global diffusion of organ transplantation: trends, drivers and policy implications (2014) (86)
A RANDOMIZED CLINICAL TRIAL COMPARING OKT3 AND STEROIDS FOR TREATMENT OF HEPATIC ALLOGRAFT REJECTION (1987) (85)
Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. (1990) (82)
Morbidity and mortality after living kidney donation, 1999-2001 (2003) (80)
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation (2003) (79)
Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. (1976) (78)
Donor Kidney Exchanges (2004) (76)
Living donor kidney transplantation in a global environment. (2007) (76)
The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant. (2014) (75)
Unsuspected donor pseudomonas infection causing arterial disruption after renal transplantation. (1984) (71)
Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. (2004) (71)
Hyperparathyroidism during pregnancy. (1976) (69)
Cadaver donor screening for infectious agents in solid organ transplantation. (2000) (68)
Changing Pattern of Organ Donation at a Single Center: Are Potential Brain Dead Donors Being Lost to Donation After Cardiac Death? (2010) (66)
Preliminary results of a liver allocation plan using a continuous medical severity score that de‐emphasizes waiting time (2001) (66)
The implications of Istanbul Declaration on organ trafficking and transplant tourism (2009) (65)
Living and Deceased Organ Donation Should Be Financially Neutral Acts (2015) (64)
A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients (2003) (60)
Expanding controlled donation after the circulatory determination of death: statement from an international collaborative (2021) (58)
The Declaration of Istanbul on organ trafficking and transplant tourism. (2008) (57)
IMMUNOGENICITY OF HEPATITIS B VACCINE IN RENAL TRANSPLANT RECIPIENTS (1985) (57)
Evolving trends in liver transplantation: an outcome and charge analysis. (1998) (57)
Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. (1989) (56)
American society of transplant surgeons' position paper on adult‐to‐adult living donor liver transplantation (2000) (54)
CARDIOVASCULAR RISK PROFILE AFTER CONVERSION FROM CYCLOSPORINE A TO TACROLIMUS IN STABLE RENAL TRANSPLANT RECIPIENTS (2004) (52)
Dynamic Challenges Inhibiting Optimal Adoption of Kidney Paired Donation: Findings of a Consensus Conference (2013) (49)
The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. (1998) (49)
New approaches to donor crossmatching and successful transplantation of highly sensitized patients. (1983) (48)
The Development of a Successful Multiregional Kidney Paired Donation Program (2008) (48)
The Use of a Minor as a Live Kidney Donor (2002) (46)
Should Pediatric Patients Wait for HLA‐DR‐Matched Renal Transplants? (2008) (45)
The need and opportunity for donation after circulatory death worldwide (2017) (44)
Managing the highly sensitized transplant recipient and B cell tolerance. (2001) (44)
In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. (1999) (42)
Clinical Results of an Organ Procurement Organization Effort to Increase Utilization of Donors after Cardiac Death (2006) (42)
Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. (1992) (40)
The Consequences of Public Policy to Buy and Sell Organs for Transplantation (2004) (38)
The prohibition of kidney sales and organ markets should remain. (2008) (38)
Analysis of the Wait List and Deaths Among Candidates Waiting for a Kidney Transplant (2008) (38)
The high-risk liver allograft recipient. Should allocation policy consider outcome? (1992) (37)
Utilizing List Exchange and Undirected Good Samaritan Donation through 'Chain' Paired Kidney Exchanges (2006) (37)
Donor renal angiography: its influence on the decision to use the right or left kidney. (1988) (37)
A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients. (1990) (37)
Transplant recipients with a history of a malignancy: risk of recurrent and de novo cancers (2005) (36)
Investigating Geographic Variation in Mortality in the Context of Organ Donation (2012) (36)
The ‘Two, One, Zero’ Decision: What to Do with Suboptimal Deceased Donor Kidneys (2010) (35)
Selective use of veno-venous bypass in orthotopic liver transplantation. (1996) (34)
Increasing the Supply of Kidneys for Transplantation (2005) (34)
Is this live-organ donor your patient? (2003) (34)
Payment for kidneys: a government-regulated system is not ethically achievable. (2006) (33)
Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys. (1998) (33)
Organ Transplantation for Nonresidents of the United States: A Policy for Transparency (2014) (32)
Impact of Blood Transfusion on Renal Transplantation (1978) (32)
Synthetic hemoglobin‐based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion (2019) (32)
Maximizing the success of transplantation with kidneys from older donors. (2006) (31)
Cure of hemophilia A by orthotopic liver transplantation. (1988) (30)
A needed Convention against trafficking in human organs (2014) (29)
The development of the Declaration of Istanbul on Organ Trafficking and Transplant Tourism. (2008) (29)
Pediatric Deceased Donation—A Report of the Transplantation Society Meeting in Geneva (2015) (29)
SRTR Center‐Specific Reporting Tools: Posttransplant Outcomes (2006) (28)
Procurement of a whole pancreas and liver from the same cadaveric donor. (1989) (28)
Why we should not pay for human organs. (2002) (28)
Differentiation between renal allograft rejection and acute tubular necrosis by renal scan. (1977) (28)
Open letter to Xi Jinping, President of the People's Republic of China: China's fight against corruption in organ transplantation. (2014) (27)
Experience with Pyeloureterostomy in Renal Transplantation (1982) (27)
Effects of virus types of RBC transfusions on HLA alloimmunization and renal allograft survival. (1977) (26)
Opposition to irresponsible global kidney exchange (2017) (26)
China organ donation and transplantation update: the Hangzhou Resolution. (2014) (26)
The Impact of Variation in Donation After Cardiac Death Policies Among Donor Hospitals: A Regional Analysis (2011) (25)
Current status of transplantation and organ donation in the Balkans--could it be improved through the South-eastern Europe Health Network (SEEHN) initiative? (2012) (25)
Long-term, low-dose cyclosporine treatment of renal allograft recipients. A randomized trial. (1990) (25)
Antithymocyte globulin as the primary treatment for renal allograft rejection. (1983) (25)
The use of local allograft irradiation following renal transplantation. (1984) (24)
Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. (2002) (24)
Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding protein. (1986) (24)
Second renal transplantations. Ethical issues clarified by outcome; outcome enhanced by a reliable crossmatch. (1994) (23)
Organ donation and dual advocacy. (2008) (23)
Parathyroid Surgery in Patients with Renal Failure (1984) (23)
Direction of the Organ Procurement and Transplantation Network and United Network for Organ Sharing Regarding the Oversight of Live Donor Transplantation and Solicitation for Organs (2006) (22)
Donor-related malignancies (2002) (21)
Long-term Outcome of a Cuffed Expanded PTFE Graft for Hemodialysis Vascular Access (2008) (21)
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction * (2004) (21)
Combined kidney and pancreas transplantation in diabetics. (1988) (21)
Organ Donation in the Era of the Opioid Crisis: A Clinical Strategy to Maximize Transplantation. (2017) (21)
CDR‐GRAFTED OKT4A MONOCLONAL ANTIBODY IN CYNOMOLGUS RENAL ALLOGRAFT RECIPIENTS1,2 (1994) (20)
Changing Patterns of Organ Donation: Brain Dead Donors Are Not Being Lost by Donation After Circulatory Death (2016) (20)
Assessing Organ Donation from the Dead Should Not Be Done by Reporting a Census of the Living (2003) (20)
Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group. (1997) (20)
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. (1999) (20)
Nonhuman primate responses to murine and humanized OKT4A. (1993) (20)
Transplant Kidneys Sooner: Discard Fewer Kidneys (2001) (19)
Interview With Dr Joseph Murray (2002) (19)
Impact of donor kidney recovery method on lymphatic complications in kidney transplantation. (2008) (18)
Renal transplantation in the older age group. (1975) (18)
Management of the renal allograft recipient: immunosuppressive protocols for long-term success. (1994) (18)
Global initiatives to tackle organ trafficking and transplant tourism (2013) (18)
Monoclonal antibody treatment of human allograft recipients. (1988) (18)
Prevention of Transnational Transplant-Related Crimes—What More Can be Done? (2016) (18)
EVOLVING TRENDS IN LIVER TRANSPLANTATION (1999) (18)
When organ donors are still patients: is premortem use of heparin ethically acceptable? (2007) (18)
Management of Patients Who Receive an Organ Transplant Abroad and Return Home for Follow-up Care: Recommendations From the Declaration of Istanbul Custodian Group (2018) (17)
Regional perspective: developing organ transplantation in sub-saharan Africa. (2014) (17)
Organ Markets: Problems Beyond Harms to Vendors (2014) (17)
A novel united network for organ sharing region kidney allocation plan improves transplant access for minority candidates. (1999) (17)
Anti-CD4 monoclonal antibody therapy. (1996) (17)
Influence of frozen blood transfusions on renal allograft survival. (1982) (16)
Towards Improving the Transfer of Care of Kidney Transplant Recipients (2017) (16)
A Roadmap for Innovation to Advance Transplant Access and Outcomes: A Position Statement From the National Kidney Foundation. (2021) (16)
Living donation: the global perspective. (2012) (16)
Parathyroid function in normocalcemic renal transplant recipients: evaluation by calcium infusion. (1991) (15)
Chronic renal allograft dysfunction: a role for mycophenolate mofetil? (2000) (15)
Improving institutional fairness to live kidney donors: donor needs must be addressed by safeguarding donation risks and compensating donation costs (2007) (15)
The hazards of transplant tourism. (2009) (15)
Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies. (1993) (15)
Twenty Year Follow Up of Histocompatibility Leukocyte Antigen-Matched Kidney and Bone Marrow Co-Transplantation for Multiple Myeloma with End Stage Renal Disease: Lessons Learned. (2019) (15)
UNOS Transplant Tumor Registry: donors with a history of cancer. (2001) (15)
Estimation of Potential Deceased Organ Donors in Canada (2016) (15)
A Colloquium on the Congress “A Gift for Life. Considerations on Organ Donation” (2009) (14)
Deceased Donor Organ Transplantation Performed in the United States for Noncitizens and Nonresidents (2018) (14)
An alternative approach to evaluating organ procurement organization performance. (1999) (14)
Human organ and tissue transplantation. Commentary (2005) (14)
The Declaration of Istanbul Is Moving Forward by Combating Transplant Commercialism and Trafficking and by Promoting Organ Donation (2012) (13)
Recurrent collapsing glomerulopathy. (1998) (13)
Risks versus benefits of contrast medium exposure in renal allograft recipients. (1983) (13)
Providing Coverage for the Unique Lifelong Health Care Needs of Living Kidney Donors Within the Framework of Financial Neutrality (2017) (12)
Transplantation of rat islets of langerhans into diabetic mice. (1977) (12)
A new allocation plan for renal transplantation. (1999) (12)
The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction. (1987) (12)
“Proposed Standards for Incentives for Organs Donation” Are Neither International nor Acceptable (2012) (12)
HORMONAL RESUSCITATION ASSOCIATED WITH MORE TRANSPLANTED ORGANS WITH NO SACRIFICE IN SURVIVAL (2004) (11)
The alternative Iranian model of living renal transplantation. (2012) (11)
The End of Racial Disparities in Kidney Transplantation? Not So Fast! (2016) (11)
Analyzing risk factors of renal transplant outcome. (2000) (10)
Contribution of native kidney function to total glomerular filtration rate after combined kidney-pancreas transplantation. (1998) (9)
Managing the Enlarging Waiting List (2002) (9)
Debate on financial incentives is off the mark of national and international realities. (2010) (9)
Death: a concept in transition. (1973) (9)
Improvement in kidney transplantation in the Balkans after the Istanbul Declaration: where do we stand today? (2015) (9)
Statement of the Declaration of Istanbul Custodian Group Regarding Payments to Families of Deceased Organ Donors (2016) (9)
A welcomed new national policy in China. (2013) (9)
A new allocation plan for renal transplantation. (1998) (8)
Transplantation of liver grafts from living donors into adults. (2001) (8)
Promotion of altruistic donation. (2009) (8)
What is the system failure? (2006) (8)
Variation in patient response associated with different preparations of murine monoclonal antibody therapy. (1989) (8)
Pediatric Kidney Transplantation in the United States: The Current Realities (2008) (8)
Temporary skin transplantation for the treatment of extensive burns. (1981) (8)
Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury (2021) (8)
Socioeconomic Status and Ethnicity of Deceased Donor Kidney Recipients Compared to Their Donors (2015) (8)
Solid organ procurement from burned children. (1999) (8)
OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients. (1991) (8)
Successful Recovery and Transplantation of 11 Organs Including Face, Bilateral Upper Extremities, and Thoracic and Abdominal Organs From a Single Deceased Organ Donor (2016) (7)
Striving to achieve a national self‐sufficiency (2011) (7)
The Pakistani revelation (2007) (7)
Preventing Trafficking in Organs for Transplantation: An Important Facet of the Fight Against Human Trafficking (2015) (7)
Individualized management of immunosuppression according to serial monitoring of immunocompetence. (1978) (7)
Organ Donor Issues for the Intensive Care Physician (1998) (7)
Research to practice: a national consensus conference. (2005) (7)
A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. (1987) (7)
Discarding the older age kidney: establishing the need for innovative utilization. (1997) (7)
Commendable developments in deceased organ donation and transplantation in Iran. (2013) (7)
First global forum on education on organ donation and transplantation for schools (2013) (7)
Case records of the Massachusetts General Hospital. Case 15-2009. A 25-year-old man with coma after cardiac arrest. (2009) (6)
The Concept of Death and Deceased Organ Donation (2010) (6)
Ureteropyelostomy with a monofilament absorbable suture. (1987) (6)
Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation. (1982) (6)
Measuring Critical Care Providers’ Attitudes About Controlled Donation After Circulatory Death (2018) (6)
Tuberculosis Outbreak in Rhesus Monkeys Immunosuppressed with Antithymocyte Globulin 1 (1978) (6)
Donation after cardiac death and the science of organ donation. (2005) (6)
1,000 renal transplants at the Massachusetts General Hospital: improved allograft survival for high-risk patients without regard to HLA matching. (1990) (6)
International Donation and Transplantation Legislative and Policy Forum: Methods and Purpose (2023) (6)
Organ Transplantation 1 A call for government accountability to achieve national self-suffi ciency in organ donation and transplantation (2011) (5)
Vancouver forum on the live lung, liver, pancreas, and intestine donor. (2006) (5)
Transplantation: Transplant tourism—an update regarding the realities (2011) (5)
Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection. (1984) (5)
The kidney transplant program at the Massachusetts general hospital. (2001) (5)
Restoring Activity of Pig Brain Cells After Death Does not Invalidate the Determination of Death by Neurologic Criteria or Undermine the Propriety of Organ Donation After Death. (2019) (5)
Donor cytokine gene polymorphisms are associated with increased graft loss and dysfunction after transplant. (2001) (5)
Transplant tourism versus proper travel for transplantation (2015) (4)
South East European Health Network Initiative for Organ Donation and Transplantation. (2015) (4)
THE EVOLUTION OF A SUCCESSFUL KIDNEY PAIRED DONATION PROGRAM: 3354 (2010) (4)
Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study. (1997) (4)
Monitoring of renal proximal tubular injury in transplantation with a monoclonal antibody based assay for the adenosine deaminase binding protein (1986) (4)
A medical defense of brain death. (1999) (4)
Monitoring immunosuppression following renal transplantation. (1983) (4)
Introduction to Vancouver Forum (2006) (4)
Organ donation and transplantation from poisoned donors (1999) (4)
Preclinical evaluation of immunosuppression selective for T cells recognizing class I histocompatibility antigens. (1987) (4)
The nondirected live-kidney donor (2002) (4)
FIRST YEAR IMPACT OF THE NEW U.S. EXPANDED CRITERIA DONOR (ECD) KIDNEY ALLOCATION SYSTEM ON THE RECOVERY AND UTILIZATION OF ECD KIDNEYS (2004) (3)
Transplantation: Can kidneys donated after cardiac death save lives? (2011) (3)
China on the brink: there is hope for the end of their use of executed prisoner organs. (2015) (3)
Phase I Clinical Trial of Anti-ICAM-1 (CD54) Monoclonal Antibody Immunosuppression in Renal Allograft Recipients (1993) (3)
Financial Neutrality in Organ Donation. (2019) (3)
Immunologic monitoring of monoclonal antibody therapy: comparison of five antibodies as immunosuppressants of renal allograft rejection. (1984) (3)
The Science and Social Necessity of Deceased Organ Donation (2011) (3)
MECHANISMS OF DONOR-SPECIFIC UNRESPONSIVENESS IN TOLERANT RECIPIENTS OF COMBINED NON-MYELOABLATIVE HLA-MISMATCHED BONE MARROW AND KIDNEY TRANSPLANTATION (2004) (3)
IMPACT OF POSITIVE HEPATITIS B AND C VIRUS DONOR SEROLOGY ON HEART AND KIDNEY ALLOGRAFT RECIPIENTS.: Abstract# 626 (2000) (3)
The international realities of live donor kidney transplantation. (2009) (3)
Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilization. (2012) (3)
The Transplantation Society Believes a Policy of Engagement Will Facilitate Organ Donation Reform in China (2016) (3)
A path of hope for organ transplantation in China? (2015) (3)
FACTORS PREDICTIVE OF THE DISCARD OF ECD KIDNEYS DO NOT PREDICT OUTCOME: 66 (2008) (3)
Commentary: The World Health Assembly resolution on human organ and tissue transplantation. (2010) (3)
KDIGO guideline for the care of kidney transplant recipients will be resource challenged. (2010) (2)
Evaluation and the psychiatric hospital. (1981) (2)
Nonhuman primate response to murine and humanized monoclonal antibodies. (1993) (2)
New Sources in Living Kidney Donation (2010) (2)
Long Term Follow-up of Recipients of Combined HLA-Matched Nonmyeloablative Bone Marrow and Kidney Transplantation for Multiple Myeloma with End-Stage Renal Disease. (2009) (2)
Societal and Professional Obligation in the Care of the Living Organ Donor. (2018) (2)
Regulated market for organs is unattainable. (2008) (2)
Research to Practice: A National Consensus Conference (2005) (2)
Kidney Transplantation in Developing Countries (2017) (2)
Assessing the motives of living, non-related donors. (2012) (2)
Human trafficking for the purpose of organ removal (2017) (2)
Organ transplantation in China--the 21st century. (2012) (2)
Organ donation and transplantation in Central America. (2015) (2)
The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation (2022) (2)
FIRST REPORT OF THE NEW INTERNATIONAL (CTTR-UNOS) TRANSPLANT TUMOR REGISTRY: U.S. DONORS WITH A HISTORY OF CANCER (1999) (2)
THE LONG-TERM CONSEQUENCES OF KIDNEY DONATION IN THE VICTIMS OF TRAFFICKING IN HUMAN BEINGS (VTHBS) FOR THE PURPOSE OF ORGAN REMOVAL: 92 (2010) (2)
The nobler angels of our nature: a tribute to Joseph E. Murray, M.D., 1919 to 2012. (2013) (2)
Neonatal Organ Donation. (2019) (1)
Organ sharing--must or myth? (1991) (1)
Deceased donors: Defining drug‐related deaths (2020) (1)
Access of non‐residents to transplantation of deceased donor organs: practices and strategies in the European setting (2021) (1)
Allocation of cadaveric donor kidneys (2000) (1)
INCIDENCE OF ACUTE HUMORAL REJECTION (AHR) IN PATIENTS WITH STEROID RESISTANT RENAL ALLOGRAFT REJECTION.: Abstract# 969 (2000) (1)
The True Meaning of Financial Neutrality in Organ Donation. (2020) (1)
Guest editorial: Organ trafficking and transplant tourism: a call for international collaboration (2013) (1)
OUTCOME OF TRANSPLANTATION OF ORGANS PROCURED FROM BACTEREMIC OR FUNGEMIC DONORS (1998) (1)
TRAVEL FOR TRANSPLANTATION: IMPACT ON LIVER TRANSPLANT CANDIDATES AND RECIPIENTS IN THE UNITED STATES (2020) (1)
Letter to the EditorThe transplant donor payment debate (2006) (1)
Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital. (1984) (1)
Immunological monitoring of diabetic and nondiabetic recipients of renal allografts. (1983) (1)
Controlled Donation after Cardiac Death (2010) (1)
Response to: Will Transplant Tourism Erode the Surgical Skills of Transplant Surgeons in Israel? (2008) (1)
Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts (1982) (1)
BK Virus: A Pathogen of 21st-Century Transplant Medicine (2002) (1)
Ethical Issues and Transplant Tourism (2014) (1)
A collaborative stewardship of OPOs and transplant centers to maintain equitable allocation when facilitating ex vivo organ preservation (2022) (1)
Methodologies for Medical Computing. Date Bases and Management Database Management: COSTAR in a Specialty Clinic: The MGH Transplant Unit System (1983) (1)
Alternate day steroids in renal transplant patients. (1977) (1)
Correction to: Expanding controlled donation after the circulatory determination of death: statement from an international collaborative (2021) (1)
The Institute of Medicine Report: Sensible and Consequential (2007) (1)
COMBINED KIDNEY AND BONE MARROW TRANSPLANTATION FOR INDUCTION OF MIXED CHIMERISM AND RENAL ALLOGRAFT TOLERANCE IN HLA MISMATCHED TRANSPLANTATION (2004) (1)
Drug regimens affect cadaveric kidney graft survival. (2001) (1)
Renal transplantation in the highly sensitized recipient. (1987) (1)
Organ Transplantation: US transplant service ??? legal and operational framework (2011) (0)
Ethically Acceptable? When Organ Donors Are Still Patients: Is Premortem Use of Heparin (2010) (0)
INTERNATIONAL PRINCIPLES OF DECEASED DONOR ORGAN ALLOCATION (EDITORIAL) (2013) (0)
History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease. (2018) (0)
TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT 3 MONOCLONAL ANTIBODY 1 A (2017) (0)
The organ thieves: The shocking story of the first heart transplant in the segregated SouthChipJonesNew York, NY: Gallery Books, 2020, 389 pages. (2020) (0)
Prioritization of Lung Transplant Recipients by Hospitalization Status Shortens Waiting Time Without Affecting Post-transplant Survival. (1999) (0)
SPECIAL SECTION: INFECTIONS IN TRANSPLANTATION AND OTHER IMMUNOCOMPROMISED HOSTS (2000) (0)
LIVER TRANSPLANTATION FOR PRIMARY HEPATIC CANCER1 (1992) (0)
A single center, retrospective study on a cuffed expanded polutetrafluoroethylene graft for hemodialysis vascular access (2006) (0)
Case 32-1997: Rocky Mountain spotted fever. (1998) (0)
Global initiatives to tackle organ trafficking and transplant tourism (2013) (0)
H. Myron Kaufman (1933–2007) Medical Director and Senior Scientist of UNOS: Transplant Surgeon and Friend (2008) (0)
ASTS Officers, Committees (2003) (0)
Author's Response. (2020) (0)
Transplant Ethics for Clinicians (2014) (0)
Critical Care Providersʼ Knowledge and Attitudes About Donation After Circulatory Death.: Abstract# B819 (2014) (0)
Lymphocytic Choriomeningitis in a Pet Store Worker in Romania (2008) (0)
Payment for donor kidneys : Pros and cons. Commentary (2006) (0)
Organ transplantation in China—not yet a new era (2014) (0)
UNOS REPORT ON CADAVERIC KIDNEY GRAFT SURVIVAL: MULTIVARIATE ANALYSIS OF DISCHARGE IMMUNOSUPPRESSIVE DRUG REGIMENS.: Abstract# 13 (2000) (0)
AN ANALYSIS OF THE LIST AND DEATHS AMONG CANDIDATES WAITING FOR A KIDNEY TRANSPLANT: 261 (2008) (0)
International Travel for Liver Transplantation: A Comprehensive Assessment of the Impact on the United States Transplant System (2021) (0)
Response to ‘Conscription of cadaveric organs for transplantation: Time to start taking about it’ (2006) (0)
THE DEVELOPMENT OF A SUCCESSFUL MULIT-REGIONAL KIDNEY PAIRED DONATION PROGRAM: 3 (2008) (0)
Determination of Brain Death. (2022) (0)
Is it ethical to pay donors for their organs (2007) (0)
Criteria for Accepting Donors with Proven or Suspected Infection for Organ Transplantation (2001) (0)
INDEX AND REVIEWS (2011) (0)
Erratum: Promotion of altruistic donation (Transplantation (2009) (847)) (2009) (0)
QS364. Longterm Outcome of a Cuffed Expanded PTFE Graft for Hemodialysis Vascular Access (2008) (0)
Chapter 33 – Surgical Aspects of Renal Transplantation (2005) (0)
Presidential address: World Transplant Congress 2014, San Francisco. (2015) (0)
Book ReviewManual of Vascular Access, Organ Donation, and Transplantation (1985) (0)
Organ donation after circulatory death: please avoid undue haste! (2021) (0)
ASTS Officers, Committees (2005) (0)
Buyer beware transplantation. (2016) (0)
Computerized matching algorithms to optimize matches and increase opportunities for live donor kidney exchange (2005) (0)
A NOVEL UNOS REGION KIDNEY ALLOCATION PLAN IMPROVES TRANSPLANT ACCESS FOR MINORITY CANDIDATES (1999) (0)
Wildes, Kevin Wm., S.J. Moral Acquaintances: Methodology in Bioethics (2001) (0)
Living Donor Transplantation: Current Practice and Future History (2003) (0)
Francis L. Delmonico, MD: The Science of Organ Donation. (2016) (0)
STRUGGLE FOR THE HISTORIC UNANIMOUS PASSAGE OF TRANSPLANT LAW IN PAKISTAN: 863 (2010) (0)
International Principles of Deceased Donor Organ Allocation (2013) (0)
Organ donation after circulatory death: please avoid undue haste! (2021) (0)
Simultaneous procurement of pancreas and liver from a single cadaveric donor. (1989) (0)
ASSOCIATION OF HEPATITIS C INFECTION WITH CHRONIC TRANSPLANT GLOMERULOPATHY AND DE NOVO MEMBRANO-PROLIFERATIVE GLOMERULAR LESIONS IN RENAL ALLOGRAFTS (1999) (0)
Extended criteria and NHB organ donation (2009) (0)
NONRESIDENT ALIEN TRANSPLANTATION IN THE UNITED STATES: 292 (2010) (0)
TREATMENT OF REFRACTORY ACUTE HUMORAL REJECTION IN KIDNEY TRANSPLANTATION.: Abstract# 672 (2000) (0)
AN ALTERNATIVE APPROACH TO EVALUATING OPO PERFORMANCE (1998) (0)
ALLORESPONSES IN TOLERANT RECIPIENTS OF COMBINED KIDNEY/BONE MARROW TRANSPLANTATION WITH NON-MYELOABLATIVE CONDITIONING (2004) (0)
Transplant Commercialism - Is It Only About The Money?: Abstract# D2696 (2014) (0)
A Current Approach to Evaluate the Risk of COVID-19 Transmission From an Organ Donor to Increase Organ Utilization. (2022) (0)
IMPACT OF DONOR AGE, DONATION AFTER CARDIAC DEATH, AND RISK OF DISEASE TRANSMISSION ON RATE OF ORGANS TRANSPLANTED PER DECEASED DONOR: 319 (2008) (0)
American Transplant Congress. Day‐at‐a‐Glance, Sunday, April 28,2002 (2002) (0)
Guest editorial: Organ trafficking and transplant tourism: a call for international collaboration (2013) (0)
Transplant Tourism into the United States (2017) (0)
SIGNIFICANCE OF ANTICARDIOLIPIN ANTIBODIES (ACA) IN RENAL ALLOGRAFT RECIPIENTS (1999) (0)
Chapter 7 – Medical Evaluation of the Living Donor (2008) (0)
FIRST YEAR’S EXPERIENCE WITH THE NEW EXPANDED CRITERIA DONOR KIDNEY ALLOCATION SYSTEM. (2004) (0)

This paper list is powered by the following services:

Other Resources About Francis L. Delmonico

en.wikipedia.org

What Schools Are Affiliated With Francis L. Delmonico?

Francis L. Delmonico is affiliated with the following schools:

Image Attributions

Image Source for Francis L. Delmonico